Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexteligent Holdings is a public OTC-traded healthcare services and health technology company focused on acquiring and operating healthcare businesses that improve provider workflow, reimbursement, and patient engagement. The company operates as an aggregator of healthcare professional services and technology firms, with activities centered on telemedicine, consulting, financial management, and revenue cycle management. Its telemedicine operations support remote care programs for eldercare providers, municipalities, and not-for-profit organizations, while its financial services operations provide coding, billing, denials recovery, and related administrative support for hospitals, clinics, physician groups, and long-term care operators. Nexteligent appears to be a healthcare services company rather than a drug-development biotech, with commercial offerings instead of a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexteligent Holdings.